SCHEMBL3385488

SCHEMBL3385488

CCC1(C)CC(=NOC(=O)c2ccccc2)C(C)C(C)(CC)N1OC(C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 3/20 0.39
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 3/20 0.31
SCN1A P35498 1/20 0.31
SCN2A Q99250 1/20 0.31
SCN3A Q9NY46 1/20 0.31
TSHR P16473 2/20 0.31
F2 P00734 1/20 0.31
HPGD P15428 1/20 0.31
ATM Q13315 1/20 0.31
CYP2C9 P11712 1/20 0.30
RAB9A P51151 1/20 0.30
CRHBP P24387 1/20 0.30
CRHR2 Q13324 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13006790 1.00 KMT2A (0.40) KMT2AMAPTMEN1LMNAL3MBTL1
SCHEMBL13006712 0.90 S1PR5 (0.30) KMT2AMEN1
SCHEMBL3386083 0.90 S1PR5 (0.30) KMT2AMEN1
SCHEMBL13006778 0.90 CYP1A2 (0.31) KMT2AMEN1LMNAMAPK1ALDH1A1
SCHEMBL3387803 0.88 MAPT (0.31) KMT2AMAPT
SCHEMBL13006710 0.88 MAPT (0.31) KMT2AMAPT
SCHEMBL14521801 0.88 ALDH1A1 (0.32) KMT2AMEN1ALDH1A1TSHRHPGD
SCHEMBL14521837 0.88 FAAH (0.30)
SCHEMBL3390625 0.87 ACHE (0.33)
SCHEMBL13006794 0.87 ACHE (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397349-B1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS BASF SE (DE) 2010-12-15 EP claimed
US-7199245-B2 Polymerizable olefin composition with imino alkoxyalkylpiperidine for controlling polymerization and free radical catalyst CIBA SPECIALTY CHEMICALS CORP. (US) 2007-04-03 US claimed
US-20040176553-A1 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators CIBA SPECIALTY CHEMICALS CORP. 2004-09-09 US claimed
EP-1397349-A1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS Ciba SC Holding AG (CH) 2004-03-17 EP claimed
WO-2002100831-A1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-12-19 WO claimed
EP-1397349-B1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS BASF SE (DE) 2010-12-15 EP disclosed
US-7199245-B2 Polymerizable olefin composition with imino alkoxyalkylpiperidine for controlling polymerization and free radical catalyst CIBA SPECIALTY CHEMICALS CORP. (US) 2007-04-03 US disclosed
US-20040176553-A1 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators CIBA SPECIALTY CHEMICALS CORP. 2004-09-09 US disclosed
EP-1397349-A1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS Ciba SC Holding AG (CH) 2004-03-17 EP disclosed
WO-2002100831-A1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176553-A1 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators PTGER4, PNMT, OPRM1 KMT2A 3054/4885MAPT 4276/4885MEN1 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.